Description
Trade name:
Davalindi 5000 IU
Compound:
Each tablet contains:
Cholecalciferol 50 mg (vitamin D3), equivalent to 5000 IU.
Auxiliary components:
Lactose monohydrate, colloidal silicon dioxide, magnesium stearate, sodium starch glycolate.
Properties:
A preparation that regulates calcium and phosphorus metabolism. Enhances calcium absorption in the intestine and phosphorus reabsorption in the renal tubules. Promotes the formation of the skeletal system and teeth in children, and the preservation of bone structure.
Vitamin D3 is necessary for the normal functioning of the parathyroid glands and also participates in the functioning of the immune system, influencing the production of lymphokines.
Participates in the process of ATP synthesis.
Indications:
Treatment of vitamin D-resistant rickets.
Treatment of hypoparathyroidism.
Method of administration and dosage:
Treatment of vitamin D-resistant rickets – from 12,000 to 500,000 IU/day.
Treatment of hypoparathyroidism – 50,000-200,000 IU.
When prescribing high doses of vitamin D, the risk of overdose is extremely high. In order to avoid unwanted side effects, it is necessary to select the dose of the drug strictly individually and regularly monitor the level of serum calcium. It is also necessary to take into account the intake of vitamin D with food.
Contraindications:
Hypercalcemia;
thyrotoxicosis (possibility of hypersensitivity);
hypervitaminosis D;
malabsorption syndrome;
hypersensitivity to vitamin D3.
Precautions:
Long-term and single administration of high doses of vitamin D can lead to hypervitaminosis. Early symptoms of hypercalcemia that occurs with hypervitaminosis include: weakness, fatigue, drowsiness, headache, loss of appetite, metallic taste in the mouth, nausea, vomiting, tinnitus, dizziness.
Side effects:
Vitamin D is generally well tolerated unless the dose recommended by your doctor is exceeded.
Storage method:
At a temperature not exceeding 30 degrees.
Package:
The cardboard box contains paper instructions and a plastic jar with 30 tablets.
